INT32314

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.49
First Reported 1986
Last Reported 1993
Negated 0
Speculated 0
Reported most in Abstract
Documents 2
Total Number 2
Disease Relevance 2.65
Pain Relevance 0.71

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Pf4) extracellular region (Pf4) protein complex assembly (Pf4)
molecular_function (Pf4) protein complex (Pf4)
Anatomy Link Frequency
platelet 2
Pf4 (Rattus norvegicus)
Pain Link Frequency Relevance Heat
Pain 1 97.44 Very High Very High Very High
Cluster headache 5 96.56 Very High Very High Very High
headache 1 85.52 High High
Migraine 1 83.96 Quite High
Percutaneous transluminal coronary angioplasty 2 75.00 Quite High
Angina 1 36.36 Quite Low
Disease Link Frequency Relevance Heat
Cardiovascular Disease 16 100.00 Very High Very High Very High
Pain 1 97.44 Very High Very High Very High
Cluster Headache 5 96.56 Very High Very High Very High
Pathologic Constriction 4 86.36 High High
Headache 1 85.52 High High
Migraine With Aura 1 83.96 Quite High
Coronary Artery Disease 1 70.48 Quite High
Myocardial Infarction 1 68.04 Quite High
Nicotine Addiction 1 66.48 Quite High
Hypertension 1 66.12 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The results indicated that statistically significantly higher levels of beta-TG and PF4 occur in the patients during the remission period when compared with the control subjects.
Positive_regulation (occur) of Positive_regulation (levels) of PF4
1) Confidence 0.49 Published 1986 Journal Cephalalgia Section Abstract Doc Link 2945644 Disease Relevance 0.68 Pain Relevance 0.68
There were no differences in lipid factors, but significant differences were observed in hemostatic variables: fibrinogen (without restenosis: 3.18 +/- 0.83; restenosis: 3.83 +/- 0.51 milligrams, p = 0.05), tissue plasminogen activator before venous occlusion (without restenosis: 10.9 +/- 26.8; restenosis: 232.5 +/- 371.2 IU, p < 0.04), euglobulin clot lysis time after venous occlusion (without restenosis: 176.5 +/- 100.5; restenosis: 78.6 +/- 40.2 min, p < 0.05) and for marker of the platelet release: platelet factor 4 (without restenosis: 10.8 +/- 7.9; restenosis: 20.5 +/- 7.5 ng/l, p < 0.04).
Positive_regulation (observed) of Positive_regulation (marker) of platelet factor 4 in platelet associated with cardiovascular disease
2) Confidence 0.03 Published 1993 Journal Int. J. Cardiol. Section Abstract Doc Link 8444504 Disease Relevance 1.97 Pain Relevance 0.04

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox